AU2022420207A1 - Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and odor derived from eicosapentaenoic acid - Google Patents

Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and odor derived from eicosapentaenoic acid Download PDF

Info

Publication number
AU2022420207A1
AU2022420207A1 AU2022420207A AU2022420207A AU2022420207A1 AU 2022420207 A1 AU2022420207 A1 AU 2022420207A1 AU 2022420207 A AU2022420207 A AU 2022420207A AU 2022420207 A AU2022420207 A AU 2022420207A AU 2022420207 A1 AU2022420207 A1 AU 2022420207A1
Authority
AU
Australia
Prior art keywords
eicosapentaenoic acid
ergothioneine
salt
derived
class compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022420207A
Other languages
English (en)
Inventor
Megumi EGUCHI
Ayuta FUNAKI
Miku SUGIZAKI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of AU2022420207A1 publication Critical patent/AU2022420207A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
AU2022420207A 2021-12-23 2022-12-15 Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and odor derived from eicosapentaenoic acid Pending AU2022420207A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021209560 2021-12-23
JP2021-209560 2021-12-23
PCT/JP2022/046213 WO2023120368A1 (ja) 2021-12-23 2022-12-15 経口組成物、及び、エルゴチオネイン又はその塩に由来する苦味及びエイコサペンタエン酸類に由来する臭みを抑制する方法

Publications (1)

Publication Number Publication Date
AU2022420207A1 true AU2022420207A1 (en) 2024-06-20

Family

ID=86902472

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022420207A Pending AU2022420207A1 (en) 2021-12-23 2022-12-15 Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and odor derived from eicosapentaenoic acid

Country Status (6)

Country Link
JP (1) JPWO2023120368A1 (https=)
KR (1) KR20240127368A (https=)
CN (1) CN118414093A (https=)
AU (1) AU2022420207A1 (https=)
TW (1) TW202342005A (https=)
WO (1) WO2023120368A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0731417A (ja) * 1993-07-20 1995-02-03 Health Eido:Kk カプセル栄養補助食品
WO2010028067A1 (en) 2008-09-02 2010-03-11 Amarin Corporation Plc Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
US20120128711A1 (en) * 2009-09-21 2012-05-24 Total Nutraceutical Solutions, Inc. Anti-inflammatory approach to prevention and suppression of post-traumatic stress disorder, traumatic brain injury, depression and associated disease states
JP2012092085A (ja) * 2010-09-28 2012-05-17 Oriza Yuka Kk ササクレヒトヨタケ及びその抽出物を用いた皮膚光老化防止剤
JP5820681B2 (ja) * 2010-10-05 2015-11-24 花王株式会社 苦味抑制剤
CA2877861A1 (en) * 2012-06-26 2014-01-03 Entia Biosciences, Inc. A nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2
JP6293553B2 (ja) * 2014-03-31 2018-03-14 株式会社ファンケル 含硫化合物の硫黄臭のマスキング方法
JP6121597B1 (ja) 2016-06-09 2017-04-26 株式会社スリービー 免疫応答活性化サイトカイン産生促進剤およびTh17細胞分化促進剤

Also Published As

Publication number Publication date
WO2023120368A1 (ja) 2023-06-29
JPWO2023120368A1 (https=) 2023-06-29
TW202342005A (zh) 2023-11-01
KR20240127368A (ko) 2024-08-22
CN118414093A (zh) 2024-07-30

Similar Documents

Publication Publication Date Title
AU2023318409A1 (en) Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof
AU2022420207A1 (en) Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and odor derived from eicosapentaenoic acid
AU2022420208A1 (en) Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and odor derived from docosahexaenoic acid
AU2022420209A1 (en) Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and smell derived from arachidonic acids
HK40114952A (zh) 口服组合物,以及抑制来自麦角硫因或其盐的苦味和来自二十碳五烯酸类的臭味的方法
HK40113456A (zh) 口服组合物,以及抑制来自麦角硫因或其盐的苦味和来自二十二碳六烯酸类的臭味的方法
HK40113736A (zh) 口服组合物,以及抑制来自麦角硫因或其盐的苦味和来自花生四烯酸类的臭味的方法
AU2023318410A1 (en) Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and odor derived from milk-derived ceramide-containing material
AU2022423515A1 (en) Oral composition and method for minimizing bitter taste resulting from ergothioneine or salt thereof and odor resulting from vitamin e
AU2023309945A1 (en) Oral composition, and method for suppressing bitterness derived from ergothioneine and off-flavor derived from glucosamine compound
AU2022417968A1 (en) Oral composition and method for suppressing bitterness derived from ergothioneine
AU2023312374A1 (en) Oral composition, and method for suppressing bitterness originating from ergothioneine or salt thereof and odor originating from chondroitin sulfate or salt thereof
HK40113453A (zh) 口服组合物以及抑制来自麦角硫因的苦味的方法
HK40124128A (zh) 口服组合物,以及抑制来自麦角硫因的苦味及来自葡萄糖胺类化合物的异味的方法
AU2022423820A1 (en) ORAL COMPOSITION, AND METHOD FOR SUPPRESSING BITTERNESS DERIVED FROM ERGOTHIONEINE AND ODOR DERIVED FROM CEREAL OIL OR γ-ORYZANOL